This document is an excerpt from the EUR-Lex website
Document 32009L0120
National transposition measures communicated by the Member States concerning:
Richtlinie 2009/120/EG der Kommission vom 14. September 2009 zur Änderung der Richtlinie 2001/83/EG des Europäischen Parlaments und des Rates zur Schaffung eines Gemeinschaftskodexes für Humanarzneimittel im Hinblick auf Arzneimittel für neuartige Therapien (Text von Bedeutung für den EWR)
OJ L 242, 15/09/2009, p. 3–12
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV) This document has been published in a special edition(s)
(HR)
The member states bear sole responsibility for all information on this site provided by them on the transposition of EU law into national law. This does not, however, prejudice the results of the verification by the Commission of the completeness and correctness of the transposition of EU law into national law as formally notified to it by the member states. The collection National transposition measures is updated weekly.
Vyhláška č. 228/2008 Sb., o registraci léčivých přípravků
Bekendtgørelse om ændring af bekendtgørelse om markedsføringstilladelse til lægemidler m.m.
EM estime MNE non nécessaire - MS does not consider NEM necessary.
Medicinal Products (Control of Wholesale Distribution) Regulations 2007 (Amendment) Regulations 2010
Medicinal Products (Control of Placing on the Market) Regulations 2007 (Amendment) Regulations 2010
Medicinal Products (Control of Manufacture) Regulations 2007 (Amendment) Regulations 2010
Pravilnik o davanju odobrenja za stavljanje lijeka u promet
Bundesgesetz, mit dem das Medizinproduktegesetz und das Arzneimittelgesetz geändert werden
Ustawa z dnia 6 września 2001 r. Prawo farmaceutyczne (tekst jednolity)